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Appraisal Critically Appraised Papers
Repetitive transcranial magnetic stimulation combined 
with treadmill training can modulate corticomotor 
inhibition and improve walking performance in people with 
Parkinson’s disease
Synopsis
Summary of: Yang Y-R, et al (2013) Combination of rTMS 
and treadmill training modulates corticomotor inhibition 
and improves walking in Parkinson disease: a randomized 
trial. Neurorehabil Neural Repair 27: 79–86. [Prepared by 
Marco YC Pang, CAP Editor.]
Question: Does adding repetitive transcranial magnetic 
stimulation (rTMS) to treadmill training modulate cortical 
excitability and improve walking in people with Parkinson’s 
disease (PD)? Design: Randomised controlled trial with 
blinded outcome assessment. Setting: A medical centre 
in Taiwan. Participants: Individuals with Parkinson’s 
disease (Hoehn and Yahr Stage 2–3), and ability to walk 
independently were key inclusion criteria. Absence of 
motor evoked potential in response to rTMS, history of 
seizure, and use of cardiac pacemaker were key exclusion 
criteria. Randomisation of 22 participants allocated 11 to 
each of the experimental and control groups. Interventions: 
Both groups underwent 12 treatment sessions over 4 weeks. 
In each session, the experimental group received rTMS 
(5 Hz) applied over the leg area of the motor cortex in the 
hemisphere contralateral to the more affected leg for 6 
minutes, immediately followed by 30 minutes of treadmill 
training. The control group received sham rTMS in addition 
to the 12 sessions of treadmill training. Outcome measures: 
The primary outcomes were indicators of corticomotor 
excitability – motor threshold, silent period, short-latency 
and long-latency intracortical inhibition – measured in 
both cerebral hemispheres. The secondary outcomes were 
comfortable and fast walking speeds, and the timed-up-and-
go test. The outcomes were measured at baseline and after 
the 4-week intervention period. Results: 20 participants 
completed the study. At the end of the 4-week intervention 
period, the increase in motor threshold of 3.5% and silent 
period of 14.0% of the contralateral hemisphere relative 
to the more affected leg was signiﬁcantly more in the 
experimental group than the control group. Signiﬁcantly 
more reduction of short-latency intracortical inhibition in the 
same hemisphere was also found in the experimental group 
relative to the control group 10.9%. The experimental group 
also had signiﬁcantly more improvement than the control 
group in fast walking speed (by 10.1 cm/s) and in the timed-
up-and-go test (by 2.0 s). No signiﬁcant differences between 
the groups were reported in other outcomes. Conclusion: 
Repetitive transcranial magnetic stimulation can enhance 
the effects on corticomotor inhibition and improvement of 
walking function induced by treadmill training in patients 
with Parkinson’s disease.
Commentary
The application of non-invasive brain stimulation in 
rehabilitation has received considerable attention recently. 
Repetitive transcranial magnetic stimulation (rTMS) 
has been shown to enhance upper and lower extremity 
functions and/or modulate cortical excitability (Gonzalez-
Garcia 2011, Khedr et al 2003, Lefaucheur et al 2004, 
Lomarev et al 2006). Yang et al (2013) are the ﬁrst to 
combine rTMS and treadmill-walking training and reported 
electrophysiological and functional changes in patients with 
Parkinson’s disease (PD). They found that the experimental 
group had signiﬁcantly more lengthening of the silent 
period, increase in resting motor threshold and gait speed 
than the sham group. These ﬁndings suggest that both 
functional improvement and possible cortico-motor plastic 
changes occur after combined rTMS and task-speciﬁc 
training. While the positive results from Yang et al (2013) 
and previous studies seem promising, the optimal dosage 
and stimulation protocol of rTMS are yet to be determined. 
Yang et al (2013) used high frequency rTMS of 5 Hz 
and stimulated the more affected side of the brain for 12 
sessions. Previous studies employed high frequency rTMS 
stimulation ranging from 5 Hz to 25 Hz, and stimulated both 
hemispheres for a total of 8–15 sessions (Gonzalez-Garcia 
2011, Khedr et al 2003, Lomarev et al 2006). Two studies 
reported that the improvement in gait performance lasted 
for 1 month (Khedr et al 2003, Lomarev et al 2006), hence 
the treatment effect beyond 1 month is not known. Although 
meta-analysis reported a positive trend of high frequency 
rTMS on reducing PD-speciﬁc impairment and disability 
level (Elahi et al 2009), most of the studies had a small 
sample size (n = 10–36). It is time to carry out large scale 
randomised controlled trials to determine the stimulation 
frequency, stimulation site and total pulse, and the number 
of treatment sessions. Further study is also needed to 
examine the long-term effect of rTMS in enhancing motor 
function and electro-physiological changes in PD.
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